Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference

ST. PAUL, Minn.--()--Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the Stifel 2021 Virtual Healthcare Conference.

Stifel 2021 Virtual Heathcare Conference
Tuesday, November 16, 2021
10:00 a.m. ET
Webcast

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com

Release Summary

Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
(651) 202-4919
j.nielsen@csi360.com